For 3 billion years, one of the major carriers of information needed for life, RNA, has had a glitch that creates errors when making copies of genetic information. Researchers at The University of Texas at Austin have developed a fix that allows RNA to accurately proofread for the first time. The new discovery, published June 23 in the journal Science, will increase precision in genetic research and could dramatically improve medicine based on a person’s genetic makeup.
Certain viruses called retroviruses can cause RNA to make copies of DNA, a process called reverse transcription. This process is notoriously prone to errors because an evolutionary ancestor of all viruses never had the ability to accurately copy genetic material.
The new innovation engineered at UT Austin is an enzyme that performs reverse transcription but can also “proofread,” or check its work while copying genetic code. The enzyme allows, for the first time, for large amounts of RNA information to be copied with near perfect accuracy.
“We created a new group of enzymes that can read the genetic information inside living cells with unprecedented accuracy,” says Jared Ellefson, a postdoctoral fellow in UT Austin’s Center for Systems and Synthetic Biology. “Overlooked by evolution, our enzyme can correct errors while copying RNA.”
Reverse transcription is mainly associated with retroviruses such as HIV. In nature, these viruses’ inability to copy DNA accurately may have helped create variety in species over time, contributing to the complexity of life as we know it.
Since discovering reverse transcription, scientists have used it to better understand genetic information related to inheritable diseases and other aspects of human health. Still, the error-prone nature of existing RNA sequencing is a problem for scientists.
“With proofreading, our new enzyme increases precision and fidelity of RNA sequencing,” says Ellefson. “Without the ability to faithfully read RNA, we cannot accurately determine the inner workings of cells. These errors can lead to misleading data in the research lab and potential misdiagnosis in the clinical lab.”
Ellefson and the team of researchers engineered the new enzyme using directed evolution to train a high-fidelity (proofreading) DNA polymerase to use RNA templates. The new enzyme, called RTX, retains the highly accurate and efficient proofreading function, while copying RNA. Accuracy is improved at least threefold, and it may be up to 10 times as accurate. This new enzyme could enhance the methods used to read RNA from cells.
“As we move towards an age of personalized medicine where everyone’s transcripts will be read out almost as easily as taking a pulse, the accuracy of the sequence information will become increasingly important,” says Andy Ellington, a professor of molecular biosciences. “The significance of this is that we can now also copy large amounts of RNA information found in modern genomes, in the form of the RNA transcripts that encode almost every aspect of our physiology. This means that diagnoses made based on genomic information are far more likely to be accurate.”
The Latest on: Genetic Sequencing
via Google News
The Latest on: Genetic Sequencing
- What patients fail to understand when they sign up for genetic studieson November 19, 2019 at 8:35 am
As genetic sequencing becomes more widespread, a disconnect is emerging between what individual patients expect to get back and what scientists are willing and able to tell them. WSJ visited MIT's ...
- HashCash Gets Into Precision Healthcare with New DNA Database Collaborationon November 19, 2019 at 8:26 am
California based HashCash Consultants is partnering with a major Pharma company, to create a Blockchain based platform for DNA sequencing for precision healthcare. PALO ALTO, Calif., Nov. 19, 2019 ...
- Every butterfly in the United States and Canada now has a genome sequenceon November 19, 2019 at 8:14 am
“These cannot be used as a tool to search for genes or gene families, as it will always be unclear what is missing from the sequence data,” says Jiggins. In addition to the draft genomes, Grishin’s ...
- Genetic Characteristics of Korean Patients with Autosomal Dominant Polycystic Kidney Disease by Targeted Exome Sequencingon November 18, 2019 at 2:23 am
First, two-thirds of the 5′ region of PKD1 are duplicated by gene conversion (GC) on chromosome 16 within six pseudogenes (PKD1P1-P6) 2. Because these pseudogenes have a sequence that is 97.7% ...
- DNA Sequencing Market 2019 Size, Share, Analysis, Global Trend, Growth Rate and Forecast 2019-2026 | Fortune Business Insightson November 15, 2019 at 4:03 am
The rising advancements in DNA sequencing technologies is expected to enable growth of the global DNA sequencing market, says Fortune Business Insights has published a premium research report on, ...
- Continuously Evolving Technologies in Sequencing to Boost the Global DNA Sequencing Marketon November 14, 2019 at 11:49 am
Nov 14, 2019 (AB Digital via COMTEX) -- DNA Sequencing Market Insight The global DNA sequencing market is estimated to display a striking CAGR of 17.64 % over the forecast period from 2018 to 2023.
- DNA sequencing Market: Emerging Trends, Gross Profit, to Stay Competitive Forecast 2025 By Top Key Playerson November 13, 2019 at 7:17 pm
DNA sequencing is an umbrella term that includes both Sangers and Non-Sangers method of sequencing. In the DNA sequencing process, DNA is extracted, fragmented, and linked to adapters and primers for ...
- Genome Sequencing in Newborns Raises Ethical Issueson November 13, 2019 at 4:22 pm
However, these tests are done to identify conditions that can be diagnosed and treated early. Sequencing all or large parts of a baby's genome at birth could reveal genetic variations that increase ...
- Genome Sequencing Equipment Market may zoom in the Cloudon November 12, 2019 at 8:37 am
Nov 12, 2019 (HTF Market Intelligence via COMTEX) -- The Exploration study offers deep assessment of the Global Genome Sequencing Equipment Market and helps market participants to gain a solid base in ...
- Sequencing the genome of every UK baby would be an ethical minefieldon November 7, 2019 at 8:59 am
Plans for the National Health Service to sequence the DNA of every baby born in the UK, starting with a pilot scheme of 20,000 children, were announced by health minister Matt Hancock this week. It ...
via Bing News